查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1435056

抗繆勒氏管激素測試市場：按產品、最終用戶、分佈和應用 - 2024-2030 年全球預測

Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年抗苗勒管激素檢測市場規模為2.7426億美元，預計2024年將達3.0541億美元，2030年將達到5.8648億美元，複合年成長率為11.46%。

抗苗勒氏管激素檢測的全球市場

主要市場統計
基準年[2023] 27426萬美元
預測年份 [2024] 30541萬美元
預測年份 [2030] 5.8648億美元
複合年成長率（%） 11.46%
抗苗勒氏管激素檢測市場-IMG1

抗苗勒氏管激素 (AMH) 測試是醫療專業人員用來評估女性卵巢儲備、生育能力和生殖健康的診斷工具。 AMH是由卵巢前週期卵泡和肛門卵泡的顆粒細胞產生的一種糖蛋白激素，透過抑制發育中的原始卵泡募集到卵泡中，在調節卵泡發育中發揮重要作用。我正在履行我的職責。測量 AMH 水平可以告訴我們女性的卵巢儲備情況以及可能發育成健康胚胎的卵子數量。 AMH 檢測在臨床上也可用於診斷卵巢症候群 (PCOS)。卵巢症候群是一種常見的內分泌疾病，會增加月經和不孕的風險。 AMH 測試是評估接受化療和骨盆腔放射線治療等治療的癌症患者發生卵巢早衰 (POI) 和提前閉經的風險的重要工具。在這些治療之前、期間和之後監測 AMH 水平可以幫助識別 POI 高風險患者，並指導採取適當措施以保留生育選擇。此外，由於女性健康疾病的增加以及體外受精和卵子冷凍治療的增加，對 AMH 檢測的需求也在增加。然而，家庭診斷套件結果不一致以及報銷方案不明確嚴重阻礙了 AMH 檢測的採用。此外，FDA核准針對更年期疾病的 AMH 檢測以及在新興市場採用自動化 AMH 檢測預計將提供重要的市場開拓機會。

區域洞察

在美洲，由於人們對不孕症的興趣增加、研發 (R&D) 力度加大以及 FDA 對 AMH 的核准迅速增加，AMH 市場正在經歷顯著成長。由於產品開發和女性不孕症的增加，美國和加拿大在 AMH 市場的區域前景中處於領先地位。在墨西哥、阿根廷和巴西，快速的都市化對不孕症的下降做出了重大貢獻，這主要是由於這些國家發生的重大社會、經濟和政治變革進一步促進了 AMH 檢測市場的成長。 。在亞太地區，由於生育中心和實驗室數量的增加、公眾意識、醫療保健及相關基礎設施的投資以及政府對 AMH 檢測的支持政策，預計 AMH 檢測市場將顯著成長。隨著需求和採用的增加，中國、日本、印度、澳洲和新加坡等主要國家看到了女性不孕症治療的正面前景。同時，在中東和非洲，阿拉伯聯合大公國、沙烏地阿拉伯、南非等主要經濟體在醫療保健領域也逐步取得了一些進展。此外，隨著政府更加重視提供支援措施以及私人醫療保健和製藥公司的意識和投資的增加，歐洲、中東和非洲地區的市場潛力預計將擴大。

FPNV定位矩陣

FPNV定位矩陣對於評估抗苗勒氏管激素檢測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對抗苗勒管激素測試市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-抗苗勒氏管激素檢測市場的市場規模與預測是多少？

2-在抗苗勒管激素測試市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-抗苗勒管激素檢測市場的技術趨勢和法律規範是什麼？

4-抗苗勒管激素測試市場主要供應商的市場佔有率是多少？

5-進入抗苗勒氏管激素檢測市場合適的型態與策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 卵巢症候群等女性健康疾病增加
      • 體外受精和卵子冷凍程序的使用增加了女性生育健康檢查的需求。
    • 抑制因素
      • 贖回選項不明確
    • 機會
      • FDA 新核准AMH 測試用於更年期
      • 自動化 AMH 測試的引入正在擴大
    • 任務
      • 與家庭診斷試劑套件相關的結果有差異
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章抗苗勒管激素檢測市場：依產品

  • POC測試
  • 自檢套件
    • 酵素連結免疫吸附測定套件
    • 快速檢測套組

第7章 抗苗勒氏管激素測試市場：依最終用戶分類

  • 商業研究所
  • 研究與開發

第8章抗苗勒氏管激素檢測市場分佈

  • 線下通路
  • 線上通路

第9章依應用分類的抗苗勒氏管激素檢測市場

  • 人類
  • 非人類的

第10章美洲抗苗勒氏管激素檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區抗苗勒氏管激素檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲抗苗勒氏管激素檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 投資、資金籌措

第14章競爭產品組合

  • 主要公司簡介
    • Abbexa Ltd.
    • Ansh Labs
    • Athenese-Dx
    • BioMerieux SA
    • Chengdu VACURE Biotechnology Co., Ltd.
    • CTK Biotech, Inc.
    • Cusabio Technology LLC
    • Danaher Corporation
    • Doctorcall Limited
    • Eagle Biosciences, Inc.
    • Elabscience, Inc.
    • enQuire Bio, LLC
    • F. Hoffmann-La Roche AG
    • Fertility 2 U Ltd
    • Goldsite Diagnostics Inc.
    • Kamiya Biomedical Co
    • LifeSpan BioSciences, Inc.
    • London Gynaecology Ltd.
    • Meridian Life Science, Inc. by SD Biosensor
    • Monobind Inc.
    • Tosoh Corporation
    • Vitall by Healthy Human Labs Ltd.
    • Vitrosens Biotechnology
    • Walk-In Lab, LLC
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-BC3400CDF7C4

[184 Pages Report] The Anti-Mullerian Hormone Test Market size was estimated at USD 274.26 million in 2023 and expected to reach USD 305.41 million in 2024, at a CAGR 11.46% to reach USD 586.48 million by 2030.

Global Anti-Mullerian Hormone Test Market

KEY MARKET STATISTICS
Base Year [2023] USD 274.26 million
Estimated Year [2024] USD 305.41 million
Forecast Year [2030] USD 586.48 million
CAGR (%) 11.46%
Anti-Mullerian Hormone Test Market - IMG1

The anti-mullerian hormone (AMH) test is a diagnostic tool healthcare professionals utilize to evaluate ovarian reserve, fertility potential, and reproductive health in women. AMH is a glycoprotein hormone created by the granulosa cells of pre-antral and antral follicles in the ovaries which plays a crucial role in regulating follicular development by inhibiting the recruitment of primordial follicles into the growing pool. Measuring AMH levels provides valuable insights into a woman's ovarian reserve, which directs to the number of eggs that can potentially develop into healthy embryos. The AMH test also has clinical utility in diagnosing polycystic ovary syndrome (PCOS), a common endocrine disorder causing irregular menstrual cycles and increased risk of infertility. AMH testing serves as an invaluable tool for assessing the risk of premature ovarian insufficiency (POI) or early menopause in cancer patients undergoing treatments such as chemotherapy or pelvic radiation therapy. Monitoring AMH levels before, during, and after these therapies help identify individuals at higher risk for POI and guide appropriate measures to preserve their fertility options. Moreover, the rising number of women's health diseases and the growing number of IVF and egg-freezing procedures raised the need for AMH tests. However, inconsistent results of in-home diagnostics kits and unclear reimbursement options significantly impede the adoption of AMH tests. In addition, emerging FDA approval of AMH test in menopausal status and the emerging adoption of automated AMH tests is expected to create tremendous opportunities for market development.

Regional Insights

In the Americas, the anti-mullerian hormone test market has experienced substantial growth due to increasing infertility concerns, rising research and development (R&D) efforts, and the surging number of approvals in AMH by the FDA in the recent period. The U.S. and Canada are heading the regional AMH market landscape with product development and increased infertility in women. In Mexico, Argentina, and Brazil, the rapid urbanization process significantly contributes to the fertility decrease, primarily linked to the country's significant social, economic, and political transformations, further contributing to the AMH test market growth. In the Asia-Pacific, the AMH test market is expected to grow significantly due to increasing infertility treatment centers & laboratories, awareness among the population, investment in healthcare & related infrastructure, and supportive government policies for AMH tests. The major economies, including China, Japan, India, Australia, and Singapore, offer positive prospects with increasing demand and adoption of female fertility care. In the EMEA region, the developed European economies represent the advanced landscape, whereas, in the Middle East & Africa, the major economies such as UAE, Saudi Arabia, and South Africa are gradually moving ahead with several developments in the healthcare sector. Moreover, rising governments focus on providing supportive measures and raising awareness and investment from private healthcare, and pharmaceutical companies are expected to expand the market's potential in the EMEA region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anti-Mullerian Hormone Test Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anti-Mullerian Hormone Test Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anti-Mullerian Hormone Test Market, highlighting leading vendors and their innovative profiles. These include Abbexa Ltd., Ansh Labs, Athenese-Dx, BioMerieux SA, Chengdu VACURE Biotechnology Co., Ltd., CTK Biotech, Inc., Cusabio Technology LLC, Danaher Corporation, Doctorcall Limited, Eagle Biosciences, Inc., Elabscience, Inc., enQuire Bio, LLC, F. Hoffmann-La Roche AG, Fertility 2 U Ltd, Goldsite Diagnostics Inc., Kamiya Biomedical Co, LifeSpan BioSciences, Inc., London Gynaecology Ltd., Meridian Life Science, Inc. by SD Biosensor, Monobind Inc., Tosoh Corporation, Vitall by Healthy Human Labs Ltd., Vitrosens Biotechnology, and Walk-In Lab, LLC.

Market Segmentation & Coverage

This research report categorizes the Anti-Mullerian Hormone Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • POC Testing
    • Self-check Kits
      • ELISA Kits
      • Rapid Test Kit
  • End-User
    • Commercial Labs
    • Research & development
  • Distribution
    • Offline Channels
    • Online Channels
  • Use
    • Human
    • Non-Human
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anti-Mullerian Hormone Test Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anti-Mullerian Hormone Test Market?

3. What are the technology trends and regulatory frameworks in the Anti-Mullerian Hormone Test Market?

4. What is the market share of the leading vendors in the Anti-Mullerian Hormone Test Market?

5. Which modes and strategic moves are suitable for entering the Anti-Mullerian Hormone Test Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anti-Mullerian Hormone Test Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Number of Women's Health Diseases such as Polycystic Ovarian Syndrome
      • 5.1.1.2. Growing Number of IVF and Egg Freezing Procedures Demand Medical Check-up of Women Fertility
    • 5.1.2. Restraints
      • 5.1.2.1. Unclear Reimbursement Options
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging FDA approval of AMH test in Menopausal Status
      • 5.1.3.2. Growing Adoption of Automated AMH Tests
    • 5.1.4. Challenges
      • 5.1.4.1. Result Inconsistencies Associated with In-home Diagnostics Kits
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anti-Mullerian Hormone Test Market, by Product

  • 6.1. Introduction
  • 6.2. POC Testing
  • 6.3. Self-check Kits
    • 6.4.1. ELISA Kits
    • 6.4.2. Rapid Test Kit

7. Anti-Mullerian Hormone Test Market, by End-User

  • 7.1. Introduction
  • 7.2. Commercial Labs
  • 7.3. Research & development

8. Anti-Mullerian Hormone Test Market, by Distribution

  • 8.1. Introduction
  • 8.2. Offline Channels
  • 8.3. Online Channels

9. Anti-Mullerian Hormone Test Market, by Use

  • 9.1. Introduction
  • 9.2. Human
  • 9.3. Non-Human

10. Americas Anti-Mullerian Hormone Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Anti-Mullerian Hormone Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Anti-Mullerian Hormone Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Quest and Proov Collaborate to Bring Novel Home Fertility Test to Women Through questhealth.com
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. LifeCell Launches Advanced Self Collection Healthcare Services
    • 13.3.3. Investment & Funding
      • 13.3.3.1. Eli Raises USD 5 Million to Make At-Home Hormone Testing for Women more Accessible

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbexa Ltd.
    • 14.1.2. Ansh Labs
    • 14.1.3. Athenese-Dx
    • 14.1.4. BioMerieux SA
    • 14.1.5. Chengdu VACURE Biotechnology Co., Ltd.
    • 14.1.6. CTK Biotech, Inc.
    • 14.1.7. Cusabio Technology LLC
    • 14.1.8. Danaher Corporation
    • 14.1.9. Doctorcall Limited
    • 14.1.10. Eagle Biosciences, Inc.
    • 14.1.11. Elabscience, Inc.
    • 14.1.12. enQuire Bio, LLC
    • 14.1.13. F. Hoffmann-La Roche AG
    • 14.1.14. Fertility 2 U Ltd
    • 14.1.15. Goldsite Diagnostics Inc.
    • 14.1.16. Kamiya Biomedical Co
    • 14.1.17. LifeSpan BioSciences, Inc.
    • 14.1.18. London Gynaecology Ltd.
    • 14.1.19. Meridian Life Science, Inc. by SD Biosensor
    • 14.1.20. Monobind Inc.
    • 14.1.21. Tosoh Corporation
    • 14.1.22. Vitall by Healthy Human Labs Ltd.
    • 14.1.23. Vitrosens Biotechnology
    • 14.1.24. Walk-In Lab, LLC
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTI-MULLERIAN HORMONE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTI-MULLERIAN HORMONE TEST MARKET DYNAMICS
  • FIGURE 7. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 12. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2030 (%)
  • FIGURE 14. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTI-MULLERIAN HORMONE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 9. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 12. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 18. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 124. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 129. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 134. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 139. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 144. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 149. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 154. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 159. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 164. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 169. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 174. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 179. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 184. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 189. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 199. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 204. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 209. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 214. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 219. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 229. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 230. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 231. ANTI-MULLERIAN HORMONE TEST MARKET LICENSE & PRICING